Covid-19 roundup: Moderna sends in EUA for bivalent teen booster; US trimming Pfizer/BioNTech donations
Though Moderna’s bivalent vaccine to counter the Omicron variant has cleared the initial hurdles in getting FDA authorization, the vaccine maker is moving on to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.